相似文献
1
NIH under fire over gene-therapy trials..
Nature. 2000 Jan 20;403(6767):237. doi: 10.1038/35002176.
2
Gene therapy investigations proliferate.
Nat Med. 2000 Mar;6(3):235. doi: 10.1038/73031.
3
Making clinical trials safer for human subjects.
Am J Law Med. 2001;27(2-3):253-82.
4
Gene therapy on trial.
Science. 2000 May 12;288(5468):951-7.
5
Gene therapy approval may be rocky road for industry.
Nature. 1995 Mar 16;374(6519):202. doi: 10.1038/374202a0.
6
Tighter watch urged on adenoviral vectors...with proposal to report all 'adverse events'.
Nature. 1999 Dec 16;402(6763):707. doi: 10.1038/45321.
7
NIH tightens up monitoring of gene-therapy mishaps.
Nature. 2000 Mar 2;404(6773):5. doi: 10.1038/35003711.
8
New rules for gene-transfer trials.
IRB. 2001 Nov-Dec;23(6):11.
9
Scrutiny of gene therapy broadens, intensifies.
Nat Biotechnol. 2000 Apr;18(4):377. doi: 10.1038/74422.
10
Light, fast, and flexible: a new approach to regulation of human gene therapy.
McGeorge Law Rev. 2000 Fall;32(1):261-87.
引用本文的文献
1
Inadequate reporting quality of registered genome editing trials: an observational study.
BMC Med Res Methodol. 2022 May 2;22(1):131. doi: 10.1186/s12874-022-01574-0.
2
Human erythropoietin gene delivery using an arginine-grafted bioreducible polymer system.
Mol Ther. 2012 Jul;20(7):1360-6. doi: 10.1038/mt.2012.62. Epub 2012 Apr 3.
3
Gene therapy: ethical issues.
Theor Med Bioeth. 2003;24(1):31-58. doi: 10.1023/a:1022967623162.
Zotero 插件